Exclusion of patients with concomitant chronic conditions in ongoing randomised controlled trials targeting 10 common chronic conditions and registered at ClinicalTrials.gov: A systematic review of registration details

BMJ Open

Volumn 6, Issue 9, 2016, Pages

  Du Vaure, Celine Buffel ^a,b   Dechartres, Agnes ^a,b,c,d   Battin, Constance ^b   Ravaud, Philippe ^a,b,c,d,e   Boutron, Isabelle ^a,b,c,d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b PARIS DESCARTES UNIVERSITY   (France)

^c HÔTEL DIEU   (France)

^d French Cochrane Center France   (France)

^e Columbia University Mailman School of Public Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC PAIN; DEMENTIA; DEPRESSION; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SELECTION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAMPLE SIZE; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK;

EID: 84989838955     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-012265     Document Type: Review

References (23)

1. Bauer UE, Briss PA, Goodman RA, et al. Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. Lancet 2014;384:45-52
2. Alwan A. Global status report on noncommunicable diseases 2010. World Health Organization, 2011
3. Salisbury C, Johnson L, Purdy S, et al. Epidemiology and impact of multimorbidity in primary care: A retrospective cohort study. Br J Gen Pract 2011;61:e12-21
4. Ward BW, Schiller JS, Goodman RA. Multiple chronic conditions among US adults: A 2012 update. Prev Chronic Dis 2014;11:4-7
5. Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study. Lancet 2012;380:37-43
6. Guthrie B, Payne K, Alderson P, et al. Adapting clinical guidelines to take account of multimorbidity. BMJ 2012;345:e6341
7. Lugtenberg M, Burgers JS, Clancy C, et al. Current guidelines have limited applicability to patients with comorbid conditions: A systematic analysis of evidence-based guidelines. PLoS ONE 2011;6:e25987
8. Tinetti ME, McAvay G, Trentalange M, et al. Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study. BMJ 2015;35:h4984
9. Guthrie B, Makubate B, Hernandez-Santiago V, et al. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010. BMC Med 2015;13:74
10. Dumbreck S, Flynn A, Nairn M, et al. Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. BMJ 2015;350:h949
11. Wallace E, Salisbury C, Guthrie B, et al. Managing patients with multimorbidity in primary care. BMJ 2015;350:h176
12. Gandhi GY, Murad MH, Fujiyoshi A, et al. Patient-important outcomes in registered diabetes trials. JAMA 2008;299:2543-9
13. Pino C, Boutron I, Ravaud P. Outcomes in registered, ongoing randomized controlled trials of patient education. PLoS ONE 2012;7:8-11
14. Van Spall HGC, Toren A, Kiss A, et al. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: A systematic sampling review. JAMA 2007;297:1233-40
15. Jadad AR, To MJ, Emara M, et al. Consideration of multiple chronic diseases in randomized controlled trials. JAMA 2011;306:2670-2
16. Smith SM, Wallace E, O'Dowd T, et al. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst Rev 2016;3: CD006560
17. Rothwell PM. Factors that can affect the external validity of randomised controlled trials. PLoS Clin Trials 2006;1:e9
18. Violan C, Foguet-Boreu Q, Flores-Mateo G, et al. Prevalence, determinants and patterns of multimorbidity in primary care: A systematic review of observational studies. PLoS ONE 2014;9: 3-11
19. Dickersin K, Rennie D. The evolution of trial registries and their use to assess the clinical trial enterprise. JAMA 2012;307:1861-4
20. Odutayo A, Altman DG, Hopewell S, et al. Reporting of a publicly accessible protocol and its association with positive study findings in cardiovascular trials (from the Epidemiological Study of Randomized Trials [ESORT]). Am J Cardiol 2015;116:1280-3
21. Goldacre B, Drysdale H, Powell-Smith A, et al. The COMPare Trials Project. 2016
22. Blümle A, Meerpohl JJ, Rucker G, et al. Reporting of eligibility criteria of randomised trials: cohort study comparing trial protocols with subsequent articles. BMJ 2011;342:d1828
23. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients. JAMA 2005;294:716-24.